3
Announcements
Trials
Browse
Landscape
Status
Completed
11
Terminated
10
Recruiting
7
Active not recruiting
7
Unknown
6
Withdrawn
4
Not yet recruiting
2
No longer available
1
Sponsor Class
OTHER
1
Study Type
Expanded_access
1
Sponsor
Cancer Type
Other hematologic neoplasm
1
Myeloid
1
Conditions
Leukemia, Myelogenous, Chronic, BCR-ABL Positive
1
Leukemia
1
Interventions
Amifampridine
4
fludarabine phosphate
3
gallium 68 PSMA-11
2
fludarabine
2
carbon-11 acetate
2
Whole-Body Irradiation
2
Magnetic Resonance Spectroscopy
2
Ga(III)-DOTATOC
2
Cyclophosphamide
2
3-Iodobenzylguanidine
2
venetoclax
1
veliparib
1
ulocuplumab
1
trametinib
1
selinexor
1
ponatinib
1
pembrolizumab
1
pegfilgrastim
1
omburtamab I-131
1
nirogacestat
1
neratinib
1
navitoclax
1
ganitumab
1
gallium Ga 68 dotatate
1
fluorodopa F 18
1
elotuzumab
1
carfilzomib
1
asparaginase erwinia chrysanthemi recombinant
1
aldesleukin
1
Vorinostat
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
No longer available
×
OTHER
×
ponatinib
×
Clear all
NCT01549548
2013-03-15
Compassionate Use Ponatinib
OHSU Knight Cancer Institute
No longer available